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Introduction
The United States of America became a nation in 1776,
when the original 13 colonies declared their independence
from the United Kingdom. Over the course of the next
several decades, its territory and population continued to
expand. Currently, it has a surface area of 9,831,510
square miles (http://data.worldbank.org/; accessed 06/19/
2017), with a population of 325,272,738 (https://www.cen
sus.gov/; accessed 06/19/2017). Thus, it represents the
third country both in area and population. In the 2010
Census, 49.1% of the population was male, and 50.9% of
the population was female, while the median age was
37.2 years. Also according to the same census, the His-
panic or Latino ethnicity represented 16.3% of the total
population, while non-Hispanic Whites represented
63.7%. Regarding race, 12.6% of the population was
Black or African American, 0.9% was American Indian
and Alaska Native, 4.8% was Asian, and 0.2% was Native
Hawaiian or other Pacific Islander.
Life expectancy at birth is 78.8 years, more specifically
81.2 years for females and 76.4 years for males (Kochanek
et al. 2016). Regarding health care expenditure, the
National Health Expenditure Accounts (NHEA) represent
the official estimates of health care spending in the coun-
try; total nominal US health care spending was $3.2 tril-
lion in 2015, with 17.8% of the gross domestic product
devoted to healthcare spending (Martin et al. 2017).
Thus, the health care cost is the highest in the world both
in totality and per capita.
History of Genetics in the United
States
As with most countries, the history of genetics in the
United States is vast. As new perspectives and application
of beliefs occurred, what was considered appropriate was
then outlawed as barbaric. For example, a dark side of its
history is represented by the popularity of the eugenics
movement during the early years of the 20th century. In
1907, Indiana became the first state to enact involuntary
sterilization legislation—a form of negative eugenics, or
improvement of the human race by removing “flawed”
individuals from the gene pool (Reilly 2015). Other states
soon followed suit, but given their almost compulsory
nature, these early laws were legally flawed. As a result of
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this, Harry H. Laughlin, the Superintendent of the Eugen-
ics Record Office at the Cold Spring Harbor Laboratory,
drafted a model eugenic sterilization law that was
reviewed by constitutional scholars. In 1924, the Com-
monwealth of Virginia enacted a law—closely based in
Laughlin’s model—that allowed eugenic sterilization of
people with intellectual disability. This law was put to the
test in 1927 with the case of Buck v. Bell, when the US
Supreme Court upheld a statute permitting compulsory
sterilization of the unfit “for the protection and health of
the state”. This legal decision opened the floodgates for a
barrage of new state legislatures allowing eugenic steriliza-
tion. After the eugenics policies of Nazi Germany came to
light at the end of World War II, the public perception
on eugenics shifted dramatically in the United States, and
the number of compulsory sterilizations decreased dra-
matically.
A more positive aspect of the history of Genetics in this
country reveals a multitude of researchers who earned
Nobel prizes for their work in the field of Genetics
(Table 1), as well as numerous genetic syndromes that
were named after American physicians, dentists, or
genetic counselors. Table 2 includes a list of eponyms, or
persons after whom syndromes have been named.
There are also toponymic diseases, that is, conditions
named after geographic locations. There are a few examples
of genetic terms named after places within the United States.
Floating-Harbor syndrome was named after the Boston
Floating Hospital where the condition was first described
(Pelletier and Feingold 1973), and the Harbor General
Hospital in Torrance, California, where a second patient
was reported (Leisti et al. 1975). Tangier disease was named
after Tangier Island in Virginia’s Chesapeake Bay, where the
condition was first identified by NIH researchers
Table 1. Representative American-born Nobel laureates who worked in the field of genetics.
Nobel laureate Research Year
Thomas Hunt Morgan “For his discoveries concerning the role played by the chromosome in heredity” 1933
George W. Beadle “For their discovery that genes act by regulating definite chemical events” 1958
Edward L. Tatum
Joshua Lederberg “For his discoveries concerning genetic recombination and the organization of the genetic
material of bacteria”
Arthur Kornberg “For their discovery of the mechanisms in the biological synthesis of ribonucleic acid and
deoxyribonucleic acid”
1959
James D. Watson “For their discoveries concerning the molecular structure of nucleic acids and its significance
for information transfer in living material”
1962
Marshall W. Nirenberg “For their interpretation of the genetic code and its function in protein synthesis” 1968
Robert W. Holley
Alfred D. Hershey For their discoveries concerning the replication mechanism and the genetic structure of
viruses”
1969
David Baltimore “For their discoveries concerning the interaction between tumour viruses and the genetic
material of the cell”
1975
Howard M. Temin
Daniel Nathans “For the discovery of restriction enzymes and their application to problems of molecular
genetics”
1978
Hamilton O. Smith
Walter Gilbert “For their contributions concerning the determination of base sequences in nucleic acids” 1980
Paul Berg “For his fundamental studies of the biochemistry of nucleic acids, with particular regard to
recombinant-DNA”
Barbara McClintock “For her discovery of mobile genetic elements” 1983
Sidney Altman “For their discovery of catalytic properties of RNA” 1989
Thomas R. Cech
Philip A. Sharp “For their discoveries of split genes” 1993
Kary B. Mullis “For his invention of the polymerase chain reaction (PCR) method” 1993
Eric F. Wieschaus “For their discoveries concerning the genetic control of early embryonic development” 1995
Edward B. Lewis
Andrew Z. Fire “For their discovery of RNA interference - gene silencing by double-stranded RNA” 2006
Craig C. Mello
Roger D. Kornberg “For his studies of the molecular basis of eukaryotic transcription” 2006
Oliver Smithies “For their discoveries of principles for introducing specific gene modifications in mice by
the use of embryonic stem cells”
2007
Carol W. Greider “For the discovery of how chromosomes are protected by telomeres and the enzyme
telomerase”
2009
Thomas A. Steitz “For studies of the structure and function of the ribosome” 2009
Paul Modrich “For mechanistic studies of DNA repair” 2015
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Table 2. Representative American eponyms in the field of genetics.
Name Syndrome Profession Reference
George S. Huntington Huntington disease General practitioner Huntington (1872)
William F. Milroy Milroy disease Internist Milroy (1892)
John B. Roberts Roberts syndrome Plastic surgeon Roberts (1919)
Edwin Pyle Pyle disease Orthopedic surgeon Pyle (1931)
Bernard J. Alpers Alpers progressive
infantile poliodystrophy
Neurologist Alpers (1931)
Myrtelle M. Canavan Canavan disease Pathologist Canavan (1931)
Donovan James McCune McCune-Albright syndrome Pediatrician McCune (1936);
Albright et al. (1937)
Fuller Albright Albright hereditary
osteodystrophy
Endocrinologist Albright et al. (1942)
Saul W. Jarcho Jarcho-Levin syndrome Internist Jarcho and Levin (1938)
Paul M. Levin Neurologist
Henry H. Turner Turner syndrome Endocrinologist Turner (1938)
Harry F. Klinefelter, Jr Klinefelter syndrome Internist Klinefelter et al. (1942)
Forrest H. Adams Adams-Oliver syndrome Cardiologist Adams and Oliver (1945)
Clarence P. Oliver Geneticist
Kenneth D. Blackfan Diamond-Blackfan anemia Pediatrician Diamond and Blackfan (1938)
Louis K. Diamond Hematologist
Harry Shwachman Shwachman-Diamond
syndrome
Gastroenterologist Shwachman et al. (1964)
Conrad M. Riley Riley-Day syndrome
(familial dysautonomia)
Pediatrician Riley et al. (1949)
Richard L. Day Pediatrician
Loren J. Larsen Larsen syndrome Orthopedic surgeon Larsen et al. (1950)
Eldon J. Gardner Gardner syndrome Geneticist Gardner (1951)
David Bloom Bloom syndrome Dermatologist Bloom (1954)
Sidney Farber Farber lipogranulomatosis Pathologist Farber (1952); Farber et al. (1957)
Thomas P. Kearns Kearns-Sayre syndrome Ophthalmologist Kearns and Sayre (1958)
George P. Sayre Ophthalmologist
Don Marshall Marshall syndrome Ophthalmologist Marshall (1958)
Klaus Patau (German-born) Patau syndrome (trisomy 13) Geneticist Patau et al. (1960)
George A. Bannayan (Israeli-born) Bannayan-Riley-Ruvalcaba
syndrome
Pathologist Riley and Smith (1960); Bannayan
(1971); Ruvalcaba et al. (1980)Harris Dr. Riley, Jr. Pediatrician
Rogelio H. A. Ruvalcaba
(Mexican-born)
Endocrinologist
Robert J. Gorlin Gorlin syndrome Oral pathologist Gorlin and Goltz (1960)
Robert W. Goltz Goltz syndrome Dermatologist Goltz et al. (1962)
Sylvester Sanfilippo Sanfilippo syndrome Pediatrician Sanfilippo et al. (1963)
Michael Lesch Lesch-Nyhan syndrome Cardiologist Lesch and Nyhan (1964)
William L. Nyhan Geneticist
Juan Fernandez Sotos Sotos syndrome Endocrinologist Sotos et al. (1964)
Philip M. Marden Marden-Walker syndrome Pediatrician Marden and Walker (1966)
W. Allan Walker Gastroenterologist
Henry T. Lynch Lynch syndrome Oncologist Lynch et al. (1966)
John C. Melnick Melnick-Needles
syndrome
Radiologist Melnick and Needles (1966)
Carl F. Needles Pediatrician
Leonard O. Langer, Jr Langer mesomelic
dysplasia
Radiologist Langer (1967)
Angelo M. DiGeorge DiGeorge syndrome Endocrinologist DiGeorge (1968)
Jacqueline A. Noonan Noonan syndrome Cardiologist Noonan (1968)
Frederick Hecht Hecht syndrome Geneticist Hecht and Beals (1969)
Ronald K. Beals Beals syndrome Orthorpedic surgeon Beals and Hecht (1971)
Ann J. Johanson Johanson-Blizzard
syndrome
Endocrinologist Johanson and Blizzard (1971)
Robert M. Blizzard Endocrinologist
Victor A. McKusick Geneticist
(Continued)
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(Fredrickson et al. 1961). Ogden syndrome was named after
the city of Ogden, Utah, where the original family was first
identified (Rope et al. 2011). The Philadelphia chromo-
some, a short chromosome 22 seen in patients with chronic
myelogenous leukemia, was first described by David
Hungerford at the Institute for Cancer Research (currently
the Fox Chase Cancer Center) and by Peter Nowell at
University of Pennsylvania, thus named after the city where
both facilities are located (Nowell and Hungerford 1960).
References to genetic conditions can also be found in
American artwork. As an example, it has been suggested
that the blacksmith depicted in the painting “Among
Those Left” by Ivan Albright had Noonan syndrome,
based on his low-set ears, short stature, and pectus defor-
mity. In addition, the great-grandson of the blacksmith
had facial features suggestive of Noonan syndrome, mild
pectus deformity, and a dysplastic pulmonary valve lead-
ing to pulmonic stenosis (Cole 1980).
Another important aspect in the history of Clinical Genet-
ics in the United States represents the establishments of
medical genetics clinics and academic divisions of Medical
Genetics, established in 1957 on both coasts of the contigu-
ous United States, by Arno Motulsky at the University of
Washington in Seattle, and by Victor McKusick at Johns
Hopkins University in Baltimore. Subsequently, Dr. David
Weyhe Smith initiated the formal study of dysmorphology
Table 2. Continued.
Name Syndrome Profession Reference
McKusick-Kaufman
syndrome
Mckusick et al. (1964);
McKusick et al. (1968);
Kaufman et al. (1972)
Robert L. Kaufman Kaufman oculocerebrofacial syndrome Geneticist Kaufman et al. (1971)
Charles D. Noonan Saldino-Noonan syndrome Radiologist Saldino and Noonan (1972)
Ronald M. Saldino Radiologist
John M. Aase Aase-Smith syndrome Geneticist Aase and Smith (1968)
Richard E. Marshall Marshall-Smith syndrome Pediatrician Marshall et al. (1971)
David Weyhe Smith Mulvihill-Smith syndrome Geneticist Mulvihill and Smith (1975)
John J. Mulvihill Geneticist
Carol N. D. Wolcott Wolcott-Rallison syndrome Pediatrician Wolcott and Rallison (1972)
Marvin L. Rallison Endocrinologist
Philip L. Townes Townes-Brocks syndrome Geneticist Townes and Brocks (1972)
Eric R. Brocks Ophthalmologist
William S. Sly Sly syndrome Geneticist Sly et al. (1973)
M. Michael Cohen, Jr Cohen syndrome Oral pathologist Cohen et al. (1973)
Jaime L. Frıas (Chilean-born) Opitz-Frias syndrome (Opitz G/BBB) Geneticist Opitz et al. (1969)
John M. Opitz (German-born) Opitz-Kaveggia syndrome (FG syndrome) Geneticist
Elizabeth G. Kaveggia (Hungarian-born) Pediatrician Opitz and Kaveggia (1974)
David D. Weaver Weaver syndrome Geneticist Weaver et al. (1974)
Robert Neil Schimke Schimke immunoosseous dysplasia Geneticist Schimke et al. (1974)
Ray M. Antley Antley-Bixler syndrome Radiologist Antley and Bixler (1975)
David Bixler Oral pathologist
Victor Escobar Escobar syndrome Geneticist Escobar et al. (1978)
Marvin E. Miller Miller syndrome Geneticist Miller et al. (1979)
Philip D. Pallister Pallister-Hall syndrome Geneticist Hall et al. (1980)
Judith G. Hall Geneticist
Selma A. Myhre Myhre syndrome Pediatrician Myhre et al. (1981)
Helga V. Toriello Toriello-Carey syndrome Geneticist Toriello and Carey (1988)
John C. Carey Geneticist
Robert M. Fineman Carey-Fineman-Ziter syndrome Geneticist Carey et al. (1982)
Fred A. Ziter Neurologist
Stephen R. Braddock Braddock-Carey syndrome Geneticist Braddock and Carey (1994)
Ann C. M. Smith Smith-Magenis syndrome Genetic counselor Smith et al. (1986)
Ruth E. Magenis Geneticist
Lisa G. Shaffer Potocki-Shaffer syndrome Geneticist Potocki and Shaffer (1996)
Lorraine Potocki Geneticist
James R. Lupski Potocki-Lupski syndrome Geneticist Potocki et al. (2000)
Maximilian Muenke (German-born) Muenke syndrome Geneticist Muenke et al. (1997)
Dorothy K. Grange Grange syndrome Geneticist Grange et al. (1998)
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in the 1960s, first at the University of Wisconsin in Madison,
and later at the University of Washington in Seattle (Frıas
2015). In fact, he coined the term dysmorphology (Smith
1966), and in 1970 published the first edition of “Recogniz-
able Patterns of Human Malformation”—widely considered
the “bible” of the field. In his honor, a group of his former
trainees started the prestigious “David Smith Workshop on
Malformations and Morphogenesis”, first held in August
1980, and annually ever since.
Demographics and Population
Diversity
The prevailing hypothesis regarding the population of the
Americas proposes that Native American ancestors came
from Siberia through the Bering Strait about 14,600 years
ago, during the Pleistocene (as during this last glacial per-
iod Beringia was not a strait but rather a land bridge).
Recent genetic studies have uncovered that this migration
from Siberia and East Asia took place about 20,000 years
ago—and no earlier than 23,000 years age—and that it
diverged into Northern (Athabascan) and Southern
(Amerindian) branches around 13,000 years ago (Ragha-
van et al. 2015). The oldest archeological complex in
North America belongs to the Clovis culture, dating from
13,000 to 12,600 years ago. Recently, the whole genome
of an infant boy (Anzick-1) belonging to the Clovis cul-
ture was sequenced at an average depth of 14.49, and it
was found that he was closely related to modern Native
American populations (Rasmussen et al. 2014). Over the
past few centuries, there has been continuous admixture
of European, African, and Native American populations
in the United States. Recent genetic studies, in fact, show
that US populations are more admixed that would be
deemed by self-reported race or ethnicity. Genome-wide
analysis of self-reported African Americans estimates an
average proportion of 73.2% African, 24.0% European,
and 0.8% Native American ancestry, while self-reported
Latinos have 18.0% Native American, 65.1% European,
and 6.2% African ancestry (Bryc et al. 2015). Approxi-
mately 3.5% of self-reported European Americans have
1% or more African ancestry—representing more than six
million Americans who self-identify as being of European
descent, but also have African ancestry. Similarly, as many
as five million self-identified European Americans have at
least 1% Native American ancestry (Bryc et al. 2015).
Various genetic isolates exist in the United States. As
an example, various genetic disorders have been described
more frequently in Inuits from Alaska (Scott 1973), in
the Athabaskans from the Southwestern United States
such as the Navajo and Apache (Erickson 1999, 2009),
and in the Anabaptists, meaning Amish, Mennonites, and
Hutterite religious groups that migrated from Europe
after the Protestant reformation (Morton et al. 2003; Boy-
cott et al. 2008). A database of genetic disorders prevalent
in Anabaptists can be found online at http://www.bioche
mgenetics.ca/plainpeople/ (Payne et al. 2011).
Regarding consanguinity studies in the general US
population, one study based on data collected in 1959
found a rate of 0.08% first-cousin, 0.02% first-cousin
once-removed, and 0.11% second-cousin marriages, for a
total of 0.21% consanguinity rate (Freire-Maia 1968),
while a subsequent study found a 0.08% consanguinity
rate among Roman Catholics in Wisconsin, USA, in the
period from 1976 to 1981 (Lebel 1983). This latter study
also showed a progressive decline in rate of first-cousin
marriage over the 20th century: 0.33% from 1902 to
1911, 0.19% from 1912 to1921, and 0.01% from 1972 to
1981. There are, however, specific religious and ethnic
minorities with high rates of consanguineous unions.
Examples of these include members of the Holiness
movement in Kentucky in the 1940s with a consanguinity
rate of 18.7% (inbreeding coefficient 0.0061) (Brown
1951), Kansas Mennonites in the 1980s with 33.0% con-
sanguinity (mean inbreeding coefficient 0.0030) (Moore
1987), and Romani Americans in Boston in the 1980s
with a 61.9% consanguinity rate (inbreeding coefficient
0.0170) (Thomas et al. 1987).
Second and third cousins may legally marry anywhere
in the United States. First cousins can get legally married,
without restrictions, in 19 states plus the District of
Columbia. In North Carolina, even though first-cousin
marriage is allowed, marriage of double first cousins is
specifically prohibited. Twenty-five states, on the other
hand, prohibit first-cousin marriage altogether. The rest
of the six states allow first-cousin marriage with some
restrictions: in Arizona only if at least one partner is
infertile, in Illinois only if both partners are over 50 years
old or one is infertile, in Maine if they submit to genetic
counseling, in Minnesota if permitted by the aboriginal
culture of the couple, in Utah if either both parties are at
least 65 years old, or if both partners are at least 55 years
old and additionally one is infertile, and in Wisconsin if
either the female partner is at least 55 years old, or either
partner is infertile. In addition, marriage of first cousins
once removed is strictly prohibited in four states (Ken-
tucky, Nevada, Ohio and Washington), while it is allowed
in Indiana and Wisconsin only if partners are over a cer-
tain age or infertile, and is allowed without restrictions in
all remaining states (Ottenheimer 1996).
Burden of Birth Defects and Genetic
Diseases in the United States
The number of infant deaths in 2014, when taking into
account all causes of infant mortality, was 23,215, for an
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infant mortality rate of 582.1 infant deaths per 100,000
live births. The leading cause of infant death belonged to
the category of congenital malformations, deformations,
and chromosomal abnormalities, as it caused 4746 infant
deaths, or 20.4% of all infant deaths—for a rate of 119.0
infant deaths per 100,000 live births. Of those, trisomy 21
accounted for 70 infant deaths (rate of 1.8 deaths per
100,000 live births), trisomy18 explained 463 infant
deaths (rate of 11.6 deaths per 100,000 live births), while
trisomy 13 was the cause of 246 infant deaths (rate of 6.2
deaths per 100,000 live births). Other chromosomal
anomalies accounted for 121 infant deaths, for a rate of
3.0 deaths per 100,000 live births (Kochanek et al. 2016).
Fortunately, between 1980 and 2001, there was a 46%
decline in infant mortality rates secondary to birth
defects, primarily related to improved medical care and
prevention (Christianson et al. 2006). Racial and ethnic
disparities, however, do exist, as postneonatal infant mor-
tality risk is significantly higher in children of non-Hispa-
nic black mothers for 13/21 birth defects (hazard ratio:
1.3–2.8) and in children of Hispanic mothers for 10/21
defects (hazard ratio: 1.3–1.7) (Wang et al. 2015).
Birth defects are not only the main reason of infant
mortality in the United States, but are also associated
with significant burden from morbidity. There are
182,786 children born annually with birth defects, for a
prevalence of 47.8 per 1000 live births (Christianson et al.
2006). Birth defects and pediatric genetic conditions
explain 12% of all pediatric visits to the hospital (CDC,
National Center on Birth Defects and Developmental Dis-
abilities). Birth defects accounted for more than 139,000
hospitalizations in 2004, for a hospitalization rate of 47.4
stays per 100,000 persons, and a total of $2.6 billion in
hospital costs for that year (Russo and Elixhauser 2007).
Trisomy 21 has an estimated number of 6037 new cases
each year (1 in 691 births), with trisomy 18 having an esti-
mated 1109 cases each year (1 in 3762 births), and trisomy
13 with an estimated annual number of 528 new cases, or 1
in 7906 births (CDC, National Center on Birth Defects and
Developmental Disabilities). In the case of trisomy 21, the
cost per new case has been estimated at $451,000 for 1992,
with a total lifetime cost of $1,848,000 (Centers for Disease
Control and Prevention (CDC) 1995).
Regarding the cost of birth defects related to pre-
ventable conditions, two diagnoses, fetal alcohol syn-
drome, and neural tube defects have been most
characterized. The total US annual cost of fetal alcohol
syndrome (FAS) for the year 2002 was estimated at $3.6
billion, while the adjusted lifetime cost for each individual
with FAS was $2.0 million (Lupton et al. 2004). An
online tool has been devised in order to calculate the
prevalence and cost of FAS in local populations (http://
www.online-clinic.com/calcs/calc-prev-cost.aspx). Folic
acid supplementation of grains led to a one-third decline
in neural tube defects per year, preventing about 500–550
cases of spina bifida each year. Since the societal cost for
a child with spina bifida has been estimated at $760,000
per year, while the cost of fortifying the food supply has
been calculated at $10 million per year, this is equivalent
to an annual $400 million cost savings (Christianson
et al. 2006). These two examples show how genetics and
public health have worked together to decrease disease
and disease costs.
Genetic Legislation in the United
States
The role of the government in protection of genetic infor-
mation for patients has been a long debated process. The
first proposal for a legislation protecting against genetic
discrimination in health insurance was the Genetic Infor-
mation Nondiscrimination Act in Health Insurance of
1995. However, this bill failed to pass either chamber of
the 104th Congress. Subsequent iterations of the bill,
which eventually expanded to protect against discrimina-
tion in employment, were introduced in each subsequent
Congress, but none of these bills were passed into law
until the 110th Congress, when the bill passed the House
with a 414-1 vote, while it unanimously passed the Sen-
ate. After 13 years spent in legislative limbo, the Genetic
Information Nondiscrimination Act of 2008 (GINA) was
finally signed into law by President George W. Bush on
May 21, 2008. Specifically, this legislation prohibits the
use of genetic information by health insurers to make
decisions about eligibility, coverage, or setting of premi-
ums (Title I), and by employers to make decisions about
hiring, salary, promotion, assignment, or firing of
employees (Title II). GINA, however, does not provide
protection in life, long-term care, and disability insurance,
and does not apply to individuals covered through vari-
ous forms of military and Federal insurance, such as TRI-
CARE, the Federal Employees Health Benefits (FEHB),
and the Veterans Health Administration (VHA).
Although GINA sets the minimum protection to be
provided against genetic discrimination, some states have
also enacted stricter legislation. To date, 35 states have
enacted laws protecting against employment discrimina-
tion and 48 states have legislation against insurance dis-
crimination based on genetic information, while 24 states
have statutes that limit the use of genetic information by
others types of insurance, such as life (17 states), long-
term care (eight states), and disability (17 states) insur-
ance (https://www.genome.gov/27552194/). California
passed CalGINA in 2011, which also prohibits discrimina-
tion in mortgage lending, housing, education, and other
state-funded programs. The National Human Genome
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Research Institute (NHGRI) keeps a database of state leg-
islature introduced since 2007 pertaining to genomic
information. Known as the Genome Statute and Legisla-
tion Database, it is updated on a monthly basis.
Another pertinent legislature includes the Americans
with Disabilities Act (ADA), signed into law by President
George H. W. Bush on July 26, 1990. This law protects
against discrimination based on disability in employment
(Title I), public entities (Title II), public accommodations
(Title III), and telecommunications (Title IV). Under this
law, disability is defined as: (1) a physical or mental
impairment that substantially limits one or more major
life activities of such individual; (2) a record of such an
impairment; or (3) being regarded as having such an
impairment. The ADA Amendments Act of 2008
(ADAAA) broadened coverage to protect any individual
facing discrimination on the basis of disability. The Equal
Employment Opportunity Commission (EEOC) provides
a list of conditions that should be regarded as disabilities,
including but not limited to deafness, blindness, intellec-
tual disability, missing limbs, autism, or epilepsy. It
should be noted, however, that the ADA does not protect
from discrimination based on genetic information alone,
but exclusively based on impairment.
Concluding Remarks
By understanding the history of genetics in the United
States, we are best able to understand its future. In this
two part series, we have begun this discussion and
included the demographics, history of genetics, and the
economic burden of genetic diseases and birth defects.
The second part of this series will address the current
status of prenatal testing, reproductive options and repro-
ductive law in the country, as well as newborn screening,
genetic services, rare disease registries, and education and
training in the field of genetics.
Online Resources
CDC—National Center on Birth Defects and Develop-
mental Disabilities. Homepage: https://www.cdc.gov/
ncbddd/birthdefects/index.html. June 15, 2017.
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